Dynamic roles of p53-mediated metabolic activities in ROS-induced stress responses

Cell Cycle

Volumn 14, Issue 18, 2015, Pages 2881-2885

  Jiang, Le ^a   Hickman, Justin H ^a   Wang, Shang Jui ^a   Gu, Wei ^a  

^a Columbia University ^*  (United States)

Author keywords

Ferroptosis; P53; ROS; SLC7A11; Transcription

Indexed keywords

PROTEIN P53; REACTIVE OXYGEN METABOLITE; AMINO ACID TRANSPORTER; IRON; SLC7A11 PROTEIN, HUMAN;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CELL DEATH; CELL FUNCTION; CONTROLLED STUDY; FERROPTOSIS; GENE REPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR DYNAMICS; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; WILD TYPE; CHEMISTRY; GENETICS; METABOLISM; PHYSIOLOGICAL STRESS; PHYSIOLOGY; TUMOR CELL LINE;

AMINO ACID TRANSPORT SYSTEM Y+; CELL DEATH; CELL LINE, TUMOR; HUMANS; IRON; REACTIVE OXYGEN SPECIES; STRESS, PHYSIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84953853432     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.1080/15384101.2015.1068479     Document Type: Article

References (28)

1. Vousden KH, Prives C. Blinded by the Light: The Growing Complexity of p53. Cell 2009; 137:413-31; PMID:19410540; http://dx.doi.org/10.1016/j.cell.2009.04.037
2. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science (New York, NY) 1991; 253:49-53; http://dx.doi.org/10.1126/science.1905840
3. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000; 408:307-10; PMID:11099028; http://dx.doi.org/10.1038/35042675
4. Li T, Kon N, Jiang L, Tan M, Ludwig T, Zhao Y, Baer R, Gu W. Tumor suppression in the absence of p53- mediated cell-cycle arrest, apoptosis, and senescence. Cell 2012; 149:1269-83; PMID:22682249; http://dx.doi.org/10.1016/j.cell.2012.04.026
5. Brady CA, Jiang D, Mello SS, Johnson TM, Jarvis LA, Kozak MM, Kenzelmann Broz D, Basak S, Park EJ, McLaughlin ME, et al. Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression. Cell 2011; 145:571-83; PMID: 21565614;http://dx.doi.org/10.1016/j.cell.2011.03.035
6. Wang SJ, Gu W. To be, or not to be: functional dilemma of p53 metabolic regulation. Curr Opin Oncol 2014; 26:78-85; PMID:24240177; http://dx.doi.org/10.1097/CCO.0000000000000024
7. Maddocks OD, Vousden KH. Metabolic regulation by p53. J Mol Med 2011; 89:237-45; PMID:21340684; http://dx.doi.org/10.1007/s00109-011-0735-5
8. Jiang L, Kon N, Li T, Wang SJ, Su T, Hibshoosh H, Baer R, Gu W. Ferroptosis as a p53-mediated activity during tumour suppression. Nature 2015; 520:57-62; PMID:25799988; http://dx.doi.org/10.1038/nature14344
9. Sato H, Tamba M, Ishii T, Bannai S. Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed oftwo distinct proteins. J Biol Chem 1999; 274:11455-8; PMID:10206947; http://dx.doi.org/10.1074/jbc.274.17.11455
10. Conrad M, Sato H. The oxidative stress-inducible cys-tine/glutamate antiporter, system x (c) (-): cystine supplier and beyond. Amino Acids 2012; 42:231-46. Epub 2011 Mar 16; PMID:21409388; http://dx.doi.org/10.1007/s00726-011-0867-5
11. Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ, Cantley AM, Yang WS, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 2012; 149:106072; PMID:22632970; http://dx.doi.org/10.1016/j.cell.2012.03.042
12. Polyak K, Waldman T, He TC, Kinzler KW, Vogel-stein B. Genetic determinants ofp53-induced apoptosis and growth arrest. Genes Dev 1996; 10:1945-52; PMID:8756351; http://dx.doi.org/10.1101/gad.10.15.1945
13. Riley T, Sontag E, Chen P, Levine A. Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 2008; 9:402-12; PMID:18431400; http://dx.doi.org/10.1038/nrm2395
14. Liu B, Chen Y, St Clair DK. ROS and p53: a versatile partnership. Free Radic Biol Med 2008; 44:1529-35; PMID:18275858; http://dx.doi.org/10.1016/j.freeradbiomed.2008.01.011
15. Budanov AV, Sablina AA, Feinstein E, Koonin EV, Chumakov PM. Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science 2004; 304:596-600; PMID:15105503; http://dx.doi.org/10.1126/science.1095569
16. Bensaad K, Tsuruta A, Selak MA, Vidal MN, Nakano K, Bartrons R, Gottlieb E, Vousden KH. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 2006; 126:107-20; PMID:16839880; http://dx.doi.org/10.1016/j.cell.2006.05.036
17. Suzuki S, Tanaka T, Poyurovsky MV, Nagano H, Mayama T, Ohkubo S, Lokshin M, Hosokawa H, Nakayama T, Suzuki Y, et al. Phosphate-activated glu- taminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species. Proc Natl Acad Sci USA 2010; 107:7461-6; PMID:20351271; http://dx.doi.org/10.1073/pnas.1002459107
18. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p53-induced apoptosis. Nature 1997; 389:300-5; PMID:9305847; http://dx.doi.org/10.1038/38525
19. Rivera A, Maxwell SA. The p53-induced gene-6 (proline oxidase) mediates apoptosis through a calcineurin- dependent pathway. J Biol Chem 2005; 280:29346-54; PMID:15914462; http://dx.doi.org/10.1074/jbc.M504852200
20. Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Dis 2009; 8:579-91; PMID:19478820; http://dx.doi.org/10.1038/nrd2803
21. Liu XX, Li XJ, Zhang B, Liang YJ, Zhou CX, Cao DX, He M, Chen GQ, He JR, Zhao Q. MicroRNA-26b is underexpressed in human breast cancer and induces cell apoptosis by targeting SLC7A11. FEBS Lett 2011;585:1363-7; PMID:21510944; http://dx.doi.org/10.1016/j.febslet.2011.04.018
22. Guo W, Zhao Y, Zhang Z, Tan N, Zhao F, Ge C, Liang L, Jia D, Chen T, Yao M, et al. Disruption of xCT inhibits cell growth via the ROS/autophagy pathway in hepatocellular carcinoma. Cancer Lett 2011; 312:55-61; PMID:21906871; http://dx.doi.org/10.1016/j.canlet.2011.07.024
23. Chen RS, Song YM, Zhou ZY, Tong T, Li Y, Fu M, Guo XL, Dong LJ, He X, Qiao HX, et al. Disruption of xCT inhibits cancer cell metastasis via the caveolin- 1/beta-catenin pathway. Oncogene 2009; 28:599-609; PMID:19015640; http://dx.doi.org/10.1038/onc.2008.414
24. Doxsee DW, Gout PW, Kurita T, Lo M, Buckley AR, Wang Y, Xue H, Karp CM, Cutz JC, Cunha GR, et al. Sulfasalazine-induced cystine starvation: potential use for prostate cancer therapy. Prostate 2007; 67:162-71; PMID:17075799; http://dx.doi.org/10.1002/pros.20508
25. Chung WJ, Lyons SA, Nelson GM, Hamza H, Gladson CL, Gillespie GY, Sontheimer H. Inhibition of cystine uptake disrupts the growth of primary brain tumors. J Neurosci 2005; 25:7101-10; PMID:16079392; http://dx.doi.org/10.1523/JNEUROSCI.5258-04.2005
26. Ishimoto T, Nagano O, Yae T, Tamada M, Motohara T, Oshima H, Oshima M, Ikeda T, Asaba R, Yagi H, et al. CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. Cancer Cell 2011; 19:387-400; PMID:21397861; http://dx.doi.org/10.1016/j.ccr.2011.01.038
27. Gout PW, Buckley AR, Simms CR, Bruchovsky N. Sulfasalazine, a potent suppressor oflymphoma growth by inhibition of the x(c)- cystine transporter: a new action for an old drug. Leukemia 2001; 15:1633-40; PMID:11587223; http://dx.doi.org/10.1038/sj.leu.2402238
28. Zhang W, Trachootham D, Liu J, Chen G, Pelicano H, Garcia-Prieto C, Lu W, Burger JA, Croce CM, Plunkett W, et al. Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia. Nat Cell Biol 2012; 14:276-86; PMID:22344033; http://dx.doi.org/10.1038/ncb2432